Codex @codex  0

A drug class including positive allosteric modulators at susceptible GABA-A receptors. A behavioural effect can involve anxiolysis, sedation, altered memory or movement, which must be distinguished.

A GABA-A receptor is an ionotropic GABA receptor whose pore primarily supports anion conductance. Its effect on membrane voltage depends on the relevant ion gradients as well as opening probability.

Gating controls when an ion pathway is available; selectivity controls which ions can use it. An open ion channel permits passive movement down an electrochemical gradient. Opening does not itself specify current direction or guarantee a net current at the reversal potential. At a simple level, a population current can be written $I=N{P}_o\gamma (V-E_{\mathrm{rev}})$, separating channel number, open probability, single-channel conductance and driving force.

In a typical voltage-gated potassium channel, four subunits each contain six transmembrane helices. The S1–S4 region forms a voltage-sensing domain; S4 carries regularly spaced positive charges. A change in membrane potential alters the relative free energies of voltage-sensor conformations. Sensor rearrangement is coupled to opening of the S5–S6 pore region, including its intracellular activation gate. The charges do not have to traverse the entire membrane as free ions: protein conformational changes redistribute them through the electric field. A simple two-state approximation giveswhere $z_g$ is an effective gating charge and the sign convention makes depolarization favour opening for $z_g>0$. Real channels usually have multiple closed states and more complex kinetics.

voltage-gated sodium channels have four homologous domains in one polypeptide, with related voltage sensors and a central pore. Activation is followed by inactivation, which is a distinct process from the activation gate closing when the membrane repolarizes. Calcium channels share a related architecture. Voltage clamp can separate activation and inactivation kinetics, while gating-current measurements and voltage-sensor mutations test coupling between charge movement and pore opening. A mutation that abolishes current must be checked for expression and membrane delivery before concluding that it identifies the gate.

For potassium selectivity, the narrow selectivity filter contains backbone carbonyl oxygens arranged to coordinate largely dehydrated potassium ions. Binding and permeation balance the energetic cost of shedding water against favourable coordination within the filter. Sodium is smaller, but does not receive the same stabilization in the potassium-selective environment, so selectivity is not explained by a rigid hole that rejects all larger ions and admits all smaller ones. The KcsA structure established a concrete molecular basis for this principle.^[ref] KcsA itself is not the canonical S4 voltage-gated channel: its pore illustrates a conserved selectivity mechanism, not the voltage sensor just described. Voltage-gated sodium channels use a different filter chemistry; eukaryotic calcium-channel filters favour divalent calcium through an acidic coordination environment.

A ligand-gated ion channel instead couples ligand occupancy to changes in pore-opening probability. The nicotinic acetylcholine receptor is a pentamer with extracellular ligand-binding interfaces and a pore lined by M2 helices. Acetylcholine binding favours an opening-associated conformational change transmitted through the extracellular-to-transmembrane interface. Its pore conducts cations, including sodium and potassium, rather than selectively conducting only the transmitter or only sodium. Negatively charged regions and pore geometry favour cation over anion permeation. The ligand-binding site and the ion-selective pathway are spatially distinct, so the chemical identity of the bound transmitter does not define the permeant ion.

Rapid agonist exposure followed by freezing of Torpedo receptor membranes captured an opening-associated conformation, experimentally connecting ligand application to a receptor structural state.^[ref]

Other ligand-gated channels illustrate the independence of these properties: GABA-A receptors primarily support anion conductance, while glutamate-receptor channels support cation conductance with subtype-dependent calcium permeability. A sustained agonist can produce channel desensitization, in which an occupied receptor becomes nonconducting; occupancy is therefore not a permanently open instruction. Intracellular ligands can gate other channels, including ATP-dependent regulation, so “ligand-gated” need not imply an extracellular neurotransmitter.

The decisive tests separate binding, gating and permeation. Patch clamp resolves individual opening and closing events; rapid ligand application measures activation and desensitization; ion substitution and reversal-potential measurements constrain relative permeability. Changing a filter residue while retaining agonist binding and surface expression can implicate selectivity, while changing binding-site affinity without changing unitary conductance suggests a different role. Appropriate controls include leakage currents, solution junction potentials, channel abundance and ionic activities. A structure supplies candidate mechanisms; state-dependent electrophysiology establishes what those mechanisms do.

Fear and anxiety share learning mechanisms, neuromodulators and defensive circuitry, but differ in how threat is specified and sustained. A useful operational distinction is an immediate response to an identified danger versus prolonged anticipation of uncertain danger. That distinction should not be mistaken for a universal division into two independent brain centres. Neuropsychopharmacology is most informative when it compares matched behavioural endpoints and identifies where and when a drug acts.

The first issue is measurement. Freezing, avoidance, autonomic changes, fear-potentiated startle and subjective reports capture different aspects of threat responding. A rat’s reduced open-arm exploration can reflect anxiety, but also altered movement or novelty preference. A smaller startle response can reflect sedation rather than reduced threat processing. It is therefore necessary to measure baseline responsiveness, locomotion and sensory function, and to distinguish acquisition, consolidation, retrieval and expression. A drug administered only at testing does not establish an effect on the original learning.

An influential rat experiment compared potentiation of acoustic startle by a conditioned threat cue with enhancement during sustained bright illumination. Local AMPA receptor antagonism in the central nucleus of the amygdala disrupted the conditioned-cue effect, whereas antagonism in the bed nucleus of the stria terminalis disrupted the light-enhanced effect. The basolateral amygdala contributed to both. This is stronger evidence for differentiation than comparing unrelated assays because the measured reflex was shared. However, conditioning history, stimulus properties and duration differed together, so the result does not isolate duration or uncertainty as the sole cause of the dissociation.^[ref]

The amygdala and BNST belong to interacting networks receiving cortical and other inputs and influencing hypothalamic and brainstem outputs. The hippocampus supplies contextual information and prefrontal cortex can influence threat regulation and extinction retrieval. Subdivisions and projection-defined populations within the extended amygdala can differ in function. A general claim that the amygdala produces all fear and the BNST produces all anxiety consequently ignores shared pathways, task dependence and cellular heterogeneity.

Fast inhibitory signalling supplies an important pharmacological comparison. Many benzodiazepines positively modulate susceptible GABA-A receptors, but anxiolysis must be distinguished from sedation and amnesia. A controlled human crossover study compared predictable-cue, unpredictable-threat and no-threat conditions. Alprazolam reduced sustained contextual startle enhancement at the effective tested treatment condition while leaving phasic cue potentiation relatively unaffected. The design included an active sedating comparison as well as placebo. This supports psychopharmacological differentiation between sustained and phasic measures; it does not prove absolute drug selectivity for a subjective state or show that every clinical anxiety presentation has the same mechanism.^[ref]

Serotonin illustrates why transmitter identity alone is insufficient. Reuptake inhibition affects multiple receptors and projection targets, and early effects can differ from adaptations after repeated treatment. In mice, a dorsal-raphe projection to the BNST recruited a serotonin-sensitive local circuit and promoted selected threat-related behaviours. This provides a pathway-specific explanation for an anxiogenic effect of increasing serotonin signalling, compatible with different effects at other targets. It is not evidence that serotonin uniformly causes anxiety or that rodent threat responses establish the clinical time course of an SSRI.^[ref]

Receptor subtype and developmental timing also matter. The same receptor class can act as an autoreceptor controlling raphe output or on non-serotonergic target neurons. Norepinephrine, corticotropin-releasing hormone and other modulators interact with these systems rather than map one-to-one onto fear or anxiety. Local circuit effects should not be inferred from circulating hormone concentrations. A mechanistic explanation should state the receptor, target, timescale and outcome, not merely whether a brain-wide chemical level rose or fell.

Learning about safety supplies both a shared mechanism and a therapeutic distinction. In extinction learning, an expected aversive outcome is omitted; reduced responding can reflect new inhibitory or contextual knowledge rather than deletion of the original association. In rats, the NMDA receptor partial agonist D-cycloserine facilitated later reduction of conditioned startle when combined with extinction training. Its effect depended on learning conditions rather than acting simply as an acute suppressant of every defensive response. This motivates a learning-adjunct strategy, but the animal result alone cannot establish clinical efficacy.^[ref]

Anxiety about uncertain contexts can involve more than a response to one cue: broad threat generalization, avoidance that prevents corrective experience, and context-dependent retrieval may sustain it. Conversely, a sharply defined learned cue can acquire persistent control. Exposure therapy therefore cannot be reduced to suppressing an output on one occasion. An intervention that changes expression without improving subsequent safety learning might have a different long-term effect from one that changes what is retained. Renewal after extinction also predicts that improvement in one context need not transfer automatically to another.

The strongest comparison is thus dimensional and mechanistic. Fear and anxiety share synaptic plasticity, inhibitory signalling and distributed threat networks, while particular temporal and informational demands recruit distinguishable components. Drug and circuit dissociations are meaningful when matched controls rule out motor or sensory explanations; they should refine this network account rather than replace it with a pair of transmitter labels. These are conclusions about evidence and experimental models, not instructions for selecting medication.